跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 479 条关于
“p62”
全部
479
临床试验
275
药物
174
机构
0
资讯
30
去年
p62 and NBR1 Levels Predict Immunotherapy Response in Liver Cancer
去年
DNA Plasmid Therapy Elenagen Shows 90% Success Rate in Treating Chronic Pain in Dogs, Signals Non-Opioid Path for Human Medicine
3个月前
RBM41 Drives Colorectal Cancer by Blocking NDRG1 Pre-mRNA Maturation, Study Reveals
2年前
PG2® Plus Chemoradiotherapy Improves Survival in Esophageal Cancer Patients
去年
Study Confirms CT-P42 Therapeutic Equivalence to Reference Aflibercept in DME
去年
China Approves First-in-Class Influenza Drug Onradivir Targeting Novel PB2 Protein
去年
Phio Pharmaceuticals' PH-762 Shows Complete Tumor Clearance in Skin Cancer Trial
去年
uniQure's AMT-162 Gene Therapy for SOD1-ALS Advances to Second Dose Cohort
去年
Anthracyclines Show Promise in Treating Rare Genetic Skin Disorder by Restoring Mutant p63 Function
去年
Phio Pharmaceuticals Secures U.S. Manufacturing Partnership for PD-1 Silencing Cancer Therapy PH-762
第 1 页,共 3 页
上一页
下一页